Activity of crude extract ofRubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor

[1]  J. Cusack,et al.  Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. , 2000, Cancer research.

[2]  M. Matsuda,et al.  Induction of apoptosis and inhibition of DNA topoisomerase-I in K-562 cells by a marine microalgal polysaccharide. , 2000, Life sciences.

[3]  N. D. Kim,et al.  Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives. , 1999, Cancer letters.

[4]  J. Jung,et al.  A cyclitol derivative as a replication inhibitor from the marine sponge Petrosia sp. , 1999, Journal of natural products.

[5]  H. Chung,et al.  Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. , 1999, International journal of oncology.

[6]  E. Im,et al.  A Novel Ursodeoxycholic Acid Derivative Induces Apoptosis in Human MCF-7 Breast Cancer Cells , 1999 .

[7]  Christian Jacques,et al.  Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer , 1998, The Lancet.

[8]  M. S. Orr,et al.  Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells. , 1998, Biochemical pharmacology.

[9]  M. Fukuoka,et al.  Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  N. Saijo,et al.  Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Kohn,et al.  Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. , 1996, Cancer research.

[12]  D. Cunningham,et al.  Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation. , 1996, European journal of cancer.

[13]  Y. Pommier,et al.  Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. , 1995, Cancer research.

[14]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[15]  D. Durham,et al.  Antibacterial Activity of Compounds from Rubus pinfaensis , 1994, Planta medica.

[16]  Y. Pommier,et al.  Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. , 1994, Leukemia & lymphoma.

[17]  S. Culine,et al.  Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. , 1994, Cancer research.

[18]  M. Kastan,et al.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways , 1994, Molecular and cellular biology.

[19]  L. Liu,et al.  DNA topoisomerases: essential enzymes and lethal targets. , 1994, Annual review of pharmacology and toxicology.

[20]  E. Podack,et al.  Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. , 1993, Biochemical and biophysical research communications.

[21]  M. Fukuoka,et al.  CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Kasai,et al.  Oleanane and ursane glucosides from Rubus species , 1992 .

[23]  D. Barron,et al.  A 4-hydroxy-β-ionone disaccharide glycoside from raspberry fruits , 1992 .

[24]  G. Rastelli,et al.  Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. , 1992, Planta medica.

[25]  R. Kasai,et al.  Minor diterpene glycosides from sweet leaves of Rubus suavissimus , 1992 .

[26]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[27]  O. Tanaka,et al.  LABDANE-TYPE DITERPENE GLYCOSIDES FROM FRUITS OF RUBUS-FOLIOLOSUS , 1991 .

[28]  K. Son,et al.  Triterpenoids from the roots ofRubus parvifolius , 1991 .

[29]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[30]  Y. Shu,et al.  A triterpene from the fruits of Rubus chingii , 1988 .

[31]  W. Chou,et al.  Diterpene glycosides from leaves of Chinese Rubus chingii and fruits of R. suavissimus, and identification of the source plant of the Chinese folk medicine "fu-pen-zi". , 1987, Chemical & pharmaceutical bulletin.

[32]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[33]  F. Gao,et al.  19α-Hydroxyursane-Type Triterpene Glucosyl Esters from the Roots of Rubus suavissimus S. LEE , 1985 .

[34]  W. Henning.  Flavonolglykoside der Erdbeeren (Fragaria x ananassa Duch.), Himbeeren (Rebus idaeus L.) und Brombeeren (Rubes fruticosus L.) , 1981 .

[35]  S. Ganguly,et al.  Rubinic acid, a triterpene acid from rubus fruticosus , 1978 .

[36]  S. Ganguly.  Sterols and triterpenes from Rubus fruticosus , 1972 .